Raymond James Trust’s Axcelis ACLS Stock Holding History

Raymond James Trust’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,228	Closed	-$408K	–	1152
2023 Q2	$408K	Buy	+2,228	New	+$321K	0.01%	746

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

WRCM

Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return

Raymond James Trust's ACLS Position: Q3 2023 in Review

Raymond James Trust sold out of Axcelis (ACLS) in Q3 2023, closing a stake of 2,228 shares — an estimated $408K sold.

Raymond James Trust first reported a position in ACLS in Q2 2023 and held it in 1 quarter. The position peaked at $408K in Q2 2023. 420 funds tracked by Wall St. Rank hold ACLS as of Q3 2023.

Raymond James Trust reported no remaining Axcelis position as of Q3 2023 after selling out during the quarter.
Raymond James Trust sold 2,228 Axcelis shares in Q3 2023, an estimated $408K.
Raymond James Trust first reported a position in Axcelis in Q2 2023 and held it in 1 quarter.
Raymond James Trust's Axcelis position peaked at $408K in Q2 2023.
420 funds tracked by Wall St. Rank held Axcelis as of Q3 2023.

Based on Raymond James Trust's 13F filing for Q3 2023, filed 14 Nov 2023.